AWARD
A -- COVID-19: HHS-NIH-NIAID-BAA2020-1: Research Area 003, Advanced Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases
- Notice Date
- 8/31/2020 6:26:52 AM
- Notice Type
- Award Notice
- NAICS
- 541715
— Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Contracting Office
- NATIONAL INSTITUTES OF HEALTH NIAID BETHESDA MD 20892 USA
- ZIP Code
- 20892
- Solicitation Number
- HHS-NIH-NIAID-BAA2020-1
- Archive Date
- 09/30/2020
- Point of Contact
- Swee L. Teo, Phone: 2406695173
- E-Mail Address
-
teosl@niaid.nih.gov
(teosl@niaid.nih.gov)
- Award Number
- 75N93020C00052
- Award Date
- 08/21/2020
- Awardee
- HDT BIO CORP. Seattle WA USA
- Award Amount
- 8252444.00
- Description
- COVID-19: This cost-reimbursement contract award was made under full and open competition. This type of contract was selected because costs cannot be adequately defined at the time of contract award. This contract is to develop and progress HDT-301, a replicon RNA encoding SARS-CoV-2 spike protein bound to lipid inorganic nanoparticle (LION) formulation to protect against COVID-19, through a Phase I clinical trial.�
- Web Link
-
SAM.gov Permalink
(https://beta.sam.gov/opp/0e331f6476c4428b84a7ce09cefde79f/view)
- Record
- SN05779421-F 20200902/200831230143 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |